PDCD1 and colorectal carcinoma: Moreover, the inhibitory receptors such as PD-1 were significantly increased in tumor tissues derived from digestive cancer patients, including the esophageal squamous-cell carcinomas (ESCC), HCC, CRC, GC, and biliary cancer [43].